AURORA ANALYTICA AS
Aurora AnalyticaTM transforms the cycles of clinical trial proposals from 7-10 days into decision-making workflows assisted by artificial intelligence. Feasibility, national strategy, and enrollment simulation based on artificial intelligence for CROs and pharmaceutical companies, developed in Norway.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
About AURORA ANALYTICA AS
Aurora AnalyticaTM transforms the cycles of clinical trial proposals from 7-10 days into decision-making workflows assisted by artificial intelligence. Feasibility, national strategy, and enrollment simulation based on artificial intelligence for CROs and pharmaceutical companies, developed in Norway. Among the main offerings, it provides a superior solution compared to the existing fragmented one; we have built the Aurora Suite. It targets manufacturers and integrators in the automotive, robotics, and medical sectors. The growth strategy seems to be linked to partnerships and ecosystem development.
The Story
In clinical and regulatory contexts, where the origin of data and the traceability of decisions directly influence site selection, sponsor proposals, and regulatory proposals, this is a significant gap. This ongoing support underscores the value and potential of our mission to transform clinical trial planning through advanced data analytics and artificial intelligence.
How AURORA ANALYTICA AS works
Business Model
B2B model2C centrato on a platform software.
Revenue Model
Recurring revenues from subscription fees or software licenses.
Products & Services
Key Products
- abbiamo costruito la Suite Aurora
Core Use Cases
- Integrazione di interfacce touch in prodotti fisici.
Market & Clients
Key Customers
Targets regulated organizations and technology teams that need to design scalable software platforms, intelligent automation, and reliable distributed systems.
Geographic Presence
How AURORA ANALYTICA AS competes
Competitive Advantages
- Ability to customize the offering based on customer needs.
- Declared technological differentiation on the product.
How AURORA ANALYTICA AS grows
Growth Strategy
The growth strategy appears to be linked to partnerships and ecosystem development.
Distribution Model
Direct distribution with a consultative sales approach.
Moat (Defensibility)
The defendable advantage seems to rely on proprietary technology or know-how.
Founding Team
Key Executives
- Intelligence Global CRO Past - CEO
- Board Matters John Hillier - Head of
- Feasibility Strategy - Head of
- Bhavish Lekh - CEO
- Espen Gudmundsen - CTO
Similar Startups
COMPLAI AS
Platform for organizing unstructured data with secure collection, retrieval, and intelligent management capabilities.
Read AnalysisDIGITAL PLANET AS
Satellite imagery and geospatial insights driving decision-making across agriculture, environment, and business.
Read AnalysisEDEN TECHNOLOGIES AS
Digital transformation and IT solutions making organizations industry-leading in their sectors.
Read AnalysisSources
- Aurora AnalyticaTM โ The Operating System for Clinical Development — auroraanalytica.com
- How Far Can AI Chat Agents Go With Clinical Trial Data? | Aurora AnalyticaTM — auroraanalytica.com
- Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation | Aurora AnalyticaTM — auroraanalytica.com
- Aurora Analytica Welcomes Espen Gudmundsen as CTO | Aurora AnalyticaTM — auroraanalytica.com
- Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway | Aurora AnalyticaTM — auroraanalytica.com
- Aurora Analytica Awarded Innovation Norway Start-up 2 Grant | Aurora AnalyticaTM — auroraanalytica.com
- Why John Hillier Joining Our Advisory Board Matters | Aurora AnalyticaTM — auroraanalytica.com
- Aurora Analytica AS (Aurora Analytica AS) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ — synapse.zhihuiya.com
- LinkedIn company page — LinkedIn